NL-OMON25546招募中不适用
Antiplatelet therapy for patients undergoing transcatheter aortic valve implantation
St Antonius Hospital, Nieuwegein, the Netherlands0 个研究点目标入组 1,000 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 1,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Patient has provided written informed consent.
- •2. Need for long-term oral anticoagulation;
- •3. Patient has provided written informed consent.
排除标准
- •1. Need for long-term oral anticoagulation;
- •2. Drug-eluting stent implantation within 3 months prior to TAVI procedure;
- •3. Bare-metal stent implantation within 1 month prior to TAVI procedure;
- •4. Allergy or intolerance to aspirin or clopidogrel.
- •1. Drug-eluting stent implantation within 3 months prior to TAVI procedure;
- •2. Bare-metal stent implantation within 1 month prior to TAVI procedure;
- •3. Use of non-vitamin K oral anticoagulation (NOAC);
- •4. Allergy or intolerance to OAC or clopidogrel.
研究者
相似试验
已完成
4 期
Antiplatelet therapy for patients undergoing transcatheter aortic valve implantatioNL-OMON45158Sint Antonius Ziekenhuis500
进行中（未招募）
1 期
Antiplatelet therapy for patients undergoing transcatheter aortic valve implantatioAortic stenosis for which a transcatheter aortic valve implantation (TAVI) is performed.MedDRA version: 19.1Level: PTClassification code 10002906Term: Aortic stenosisSystem Organ Class: 10047065 - Vascular disordersEUCTR2013-003125-28-GBSt. Antonius Hospital1,000
进行中（未招募）
1 期
Antiplatelet therapy for patients undergoing transcatheter aortic valve implantatioEUCTR2013-003125-28-BESt. Antonius Hospital1,000
进行中（未招募）
1 期
Antiplatelet therapy for patients undergoing transcatheter aortic valve implantatioAortic stenosis for which a transcatheter aortic valve implantation (TAVI) is performed.EUCTR2013-003125-28-NLSt. Antonius Hospital2,200
招募中
不适用
Perioperative Antiplatelet therapy in patients with drug-eluting Stent undergoing noncardiac SURgEryKCT0002907Asan Medical Center1,000